|
|
|
|
Towards elimination: A clinical and public health approach to control of hepatitis C and B infection in England
|
|
|
EASL 2022 June 22-26 London
Prof. Graham R Foster
Prof Hepatology QMUL/Barts Health
NHSE Clinical Lead for HCV
every network has a target & we monitor them on week by week basis.
programs we have initiated.
tough to implement..
increase in liver cancers in part due to not doing surveillance post cure. all too often patients fall out of the scanning process - with the marginalised groups we are treating follow up attendance is poor. We are trying to address this with a program of out-reach scanning involving community vans with peers, hopefully that will improve things but, I suspect, we are going to see a rise in HCC
|
|
|
|
|
|
|